Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
44
datasets available to search
ShareScore release 0.9.0
Dataset results
44 results for “Oligoprogression”
SBRT in HCC With Oligoprogression on Atezo-Bev
ClinicalTrials.gov study NCT06434480. IPD Sharing: NO. Countries: 1. Publications: 0.
Stereotactic Body Radiotherapy or Standard of Care for Prostate Oligoprogressive Cancer
ClinicalTrials.gov study NCT06927635. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer
ClinicalTrials.gov study NCT06585007. IPD Sharing: NO. Countries: 1. Publications: 0.
LAT for Oligoprogressive NSCLC Treated With First-line OSImertinib
ClinicalTrials.gov study NCT04216121. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro-Breast)
ClinicalTrials.gov study NCT06925984. IPD Sharing: NO. Countries: 1. Publications: 0.
Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy
ClinicalTrials.gov study NCT04892953. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Atezolizumab Plus 8 Gy Single-fraction Radiotherapy for Advanced Oligoprogressive NSCLC
ClinicalTrials.gov study NCT04549428. IPD Sharing: NO. Countries: 1. Publications: 0.
Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)
ClinicalTrials.gov study NCT04070209. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SBRT for Oligoprogressive NSCLC After First Line Treatment With Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT05387044. IPD Sharing: NO. Countries: 1. Publications: 0.
Immune Response Evaluation in Oligorecurrent and Oligoprogressive Prostate Cancer Patients Treated With SBRT
ClinicalTrials.gov study NCT04624828. IPD Sharing: NO. Countries: 1. Publications: 0.
Consolidative Use of Radiotherapy to Block Oligoprogression in Patients With Metastatic Melanoma
ClinicalTrials.gov study NCT07112170. IPD Sharing: NO. Countries: 1. Publications: 0.
LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)
ClinicalTrials.gov study NCT06103682. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study on Using SFRT With Standard Treatment for Oligoprogressive NSCLC
ClinicalTrials.gov study NCT07193641. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma
ClinicalTrials.gov study NCT04974671. IPD Sharing: NO. Countries: 1. Publications: 0.
Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT06260033. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy
ClinicalTrials.gov study NCT06055881. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Stereotactic Radiotherapy Versus Palliative Conventional Radiotherapy for Oligoprogressive Metastatic Cancers
ClinicalTrials.gov study NCT06918951. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC）
ClinicalTrials.gov study NCT07076693. IPD Sharing: YES. Countries: 1. Publications: 0.
Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic Treatment
ClinicalTrials.gov study NCT06592612. IPD Sharing: YES. Countries: 0. Publications: 0.
Local Consolidative Radiotherapy for Oligoprogressive in Non-small Cell Lung Carcinoma
ClinicalTrials.gov study NCT04485026. IPD Sharing: NO. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.